Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients… https://t.co/68QuQj2ik5
    about 9 hours ago
  • New post on Science and Enterprise: FDA Clears Stem Cell Trial for Multiple Sclerosis https://t.co/iLohWcDKEC #Science #Business
    about 9 hours ago
  • A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer's… https://t.co/YBoAZKBjBw
    about 1 day ago
  • New post on Science and Enterprise: Alzheimer’s Digital Biomarkers Project Gains New Funds https://t.co/lxhfwd4Bzi #Science #Business
    about 1 day ago
  • Shionogi starts clinical test on oral COVID drug | NHK WORLD-JAPAN News https://t.co/EAQvk9nGjw
    about 2 days ago

Please share Science & Enterprise

Alzheimer’s Digital Biomarkers Project Gains New Funds

Brain circuits illustration

A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer’s disease and other forms of dementia. . . . → Read More: Alzheimer’s Digital Biomarkers Project Gains New Funds

3-D Printed Scaffold Helps Regrow Soft Tissue

Printed tissue scaffolds

Researchers developed a biodegradable polymer for printed implant scaffolds that in lab rodents maintains its shape to encourage cell and tissue growth. . . . → Read More: 3-D Printed Scaffold Helps Regrow Soft Tissue

GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal

Brain activity graphic

GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders. . . . → Read More: GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal

Biotechs Partner on Lower Cost AI-Designed Drugs

Artificial intelligence graphic

Two biotechnology companies are collaborating on discovery and development of new drugs designed with artificial intelligence, at lower cost to patients. . . . → Read More: Biotechs Partner on Lower Cost AI-Designed Drugs

Antibodies Help Some Hospitalized Covid-19 Patients

Hospital room

Results from a clinical trial show a combination of two synthetic antibodies reduces deaths in hospitalized Covid-19 patients with no earlier immune response. . . . → Read More: Antibodies Help Some Hospitalized Covid-19 Patients

Plant-Based Material Designed to Replace Plastics

Uses of plant-based material

Biochemists created a polymer film derived from soy proteins in a sustainable process that can replace many of today’s single-use plastics. . . . → Read More: Plant-Based Material Designed to Replace Plastics

New Biotech Creating Precision Cancer Therapies

DNA analysis graphic

A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer. . . . → Read More: New Biotech Creating Precision Cancer Therapies

Multiple Organs Impaired in Long Covid-19 Patients

MRI scan of kidneys

A study of individuals with lingering symptoms from Covid-19 shows they experience impaired organ functions months after the initial infections. . . . → Read More: Multiple Organs Impaired in Long Covid-19 Patients

Trial Shows Malaria Vaccine Protects Young Children

Malaria clinic in Cameroon

Results from a clinical trial in Burkina Faso show a high efficacy rate for a candidate vaccine to protect young children against malaria infections. . . . → Read More: Trial Shows Malaria Vaccine Protects Young Children

Challenge Trial Testing Covid-19 Reinfection

SARS-Cov-2 virus

A clinical trial is underway testing immune responses from new Covid-19 infections in volunteers previously infected with the virus. . . . → Read More: Challenge Trial Testing Covid-19 Reinfection